Phylos Bioscience
PrivateLast Round
Debt
Dec 31, 2025
Total Funding Raised
$29.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phylos Bioscience is a crop science company that develops and sells advanced cannabis and hemp genetics, including F1 hybrid seeds and natural THCV products, to empower growers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phylos Bioscience Comparables
Compare Phylos Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dewey Scientific | 85% | |
| Sunrise Genetics | 85% | |
| Medicinal Genomics | 84% |
Phylos Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 31, 2025 | ||||
| Strategic | Dec 31, 2024 | ||||
| Seed Round | Jan 24, 2024 | ||||
| Convertible Debt | May 25, 2023 | ||||
| Series B | Feb 1, 2022 | ||||
VC Round | May 29, 2018 |
Key People
Founding team and executive leadership
Phylos Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accomplice | Series B |
| Entourage Effect Capital | Series B |
| Merida Capital Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 54% MoM.
- Jul 20, 2026
Open roles increased to 49, 98% of headcount.
Phylos Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Phylos Bioscience's valuation, stock price, and market status.
Is Phylos Bioscience a public or private company?
Phylos Bioscience is a private company.
What is the current stock price of Phylos Bioscience?
Phylos Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Phylos Bioscience worth (valuation)?
Valuation information for Phylos Bioscience is not publicly available.
Can I buy Phylos Bioscience stock?
Phylos Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Phylos Bioscience's last funding round?
Phylos Bioscience's most recent funding round was Strategic on December 31, 2024.
Who are the main investors in Phylos Bioscience?
Key investors in Phylos Bioscience include Organigram Global Inc., Merida Capital Partners.
Will Phylos Bioscience IPO soon?
No public IPO plans have been announced for Phylos Bioscience.
How can I track Phylos Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phylos Bioscience's secondary market activity and sign up for updates.